Cellular and T cell engager Immunotherapy
Development of a Quantitative Systems Pharmacology (QSP) model describing T-cell bispecific induced immune activation and Multiple Myeloma (MM) cell killing
Cristina Santini, PhD (she/her/hers)
Disease Modeller
F. Hoffmann-La Roche Ltd
Basel, Basel-Stadt, Switzerland